Brand-Ad-30-6
 IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 2624 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
   Next article
   Previous article 
   Table of Contents
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
   Article in PDF (141 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   Abstract
   Introduction
   Status of Cryoth...
   Cryogen
   Methodology of C...
   Conclusion
   References

 Article Access Statistics
    Viewed19534    
    Printed382    
    Emailed13    
    PDF Downloaded1612    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 


 
RECOMMENDATIONS
Year : 2009  |  Volume : 75  |  Issue : 8  |  Page : 90-100

Guidelines for cryotherapy


Members, IADVL Taskforce on Dermatosurgery, 2008-2009*, Department of Dermatology and Venereology, AIIMS, New Delhi, India

Date of Web Publication11-Aug-2009

Correspondence Address:
Vinod K Sharma
Department of Dermatology and Venereology, AIIMS, New Delhi
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

  Abstract 

Introduction: Cryotherapy is a controlled and targeted destruction of diseased tissue by the application of low temperatures. It is a simple, cost-effective, efficacious and esthetically acceptable modality for the treatment of various dermatoses. Indications: It is indicated in the treatment of a wide variety of skin conditions, including benign tumors, acne, pigmented lesions, viral infections, inflammatory dermatoses, infectious disorders and various pre-malignant and malignant tumors. Facility: Cryosurgery is an out patient department procedure and can be undertaken in a clinic or minor procedure room. Instrumentation and Equipment: Several cryogens such as liquid nitrogen, nitrous oxide and carbon dioxide are available, but liquid nitrogen is the most commonly used. Techniques: Different techniques of application of the cryogen include the timed spot freeze technique (open spray and confined spray method), use of cryoprobe or the dipstick method. The choice of the method is based on the type of lesion. The procedure is undertaken under aseptic conditions, usually without any anesthesia. The number of freeze thaw cycles needed may vary from lesion to lesion. It is important to know the freeze time for each condition, number of sessions required and the interval between the sessions to achieve good cosmetic results with minimal complications. Contraindications: The treating physician should be aware of the absolute and relative contraindications of the procedure, such as cold urticaria, cryoglobulinemia, Raynaud's disease, collagen vascular diseases, etc. Complications: While cryosurgery is usually a safe procedure, complications may occur due to inappropriate patient selection, improper duration of freezing and freeze thaw cycles. The complications may be acute, delayed or protracted. In Indian skin, post-inflammatory pigmentary changes are important but are usually transient. Physician qualification: Cryotherapy may be administered by a dermatologist who has acquired adequate training during post-graduation or through recognized fellowships and workshops dedicated to cryotherapy. He should have adequate knowledge of the equipment and pre- and post-operative care. Understanding the underlying pathology of the lesion to be treated, particularly in malignant and pre-malignant lesions, is important.


Keywords: Cryosurgery, Dermatosurgery


How to cite this article:
Sharma VK, Khandpur S. Guidelines for cryotherapy. Indian J Dermatol Venereol Leprol 2009;75, Suppl S2:90-100

How to cite this URL:
Sharma VK, Khandpur S. Guidelines for cryotherapy. Indian J Dermatol Venereol Leprol [serial online] 2009 [cited 2020 Jul 5];75, Suppl S2:90-100. Available from: http://www.ijdvl.com/text.asp?2009/75/8/90/54977



  Introduction Top


Cryotherapy is a controlled and targeted destruction of diseased tissue by the application of cold temperature substance. It is used for the treatment of diverse benign lesions and well-circumscribed pre-malignant and malignant tumors.


  Status of Cryotherapy in the Present Era Top


In the present age, despite the advent of several ablative procedures like radiofrequency or laser therapy, cryosurgery continues to occupy a very important position in the therapeutic armamentarium of a dermatologist. It is a very safe, inexpensive, reproducible, repeatable and simple office procedure. It requires a short preparation time, is a sutureless procedure with minimal risk of infection and no anesthesia is usually required. It can be performed at any age, including in old patients with pacemakers in whom electrocautery is contraindicated, those on anticoagulants, patients allergic to anesthetic agents, patients with transmissible conditions such as human immunodeficiency virus (HIV) and hepatitis, during pregnancy and over most of the body sites. It provides high healing rates even in difficult areas, with excellent cosmetic results if performed appropriately. In view of all these advantages, it is regarded as a treatment of choice by many dermatologists for various benign and malignant dermatoses.

Theoretical background: mechanism of cryoablation

Tissue destruction occurs as a result of rapid heat transfer from the tissue causing tissue injury, vascular stasis and occlusion and inflammation.

On spraying the cryogen, there is a rapid transfer of heat from the tissue to the cryogen, with ice formation in the extracellular compartment. The extracellular solutes are concentrated, setting up an osmotic gradient, with movement of fluid extracellularly and concentration of solutes within the cell leading to cell damage. The ice crystals also damage the cell membrane mechanically. Moreover, intracellular ice formation occurs, damaging organelles like mitochondria and endoplasmic reticulum. There is severe vasoconstriction and endothelial damage due to cold temperature leading to platelet aggregation and microthrombi formation, producing ischemic necrosis of the tissue. There is inflammation in response to cell death causing further destruction. [1],[2],[3],[4],[5],[6],[7],[8],[9],[10],[11],[12],[13],[14],[15]

There is differential sensitivity of each cell or tissue to cryodamage, with melanocytes and deeper epidermal cell layers being very sensitive and dermal collagen being cryoresistant.

Rationale and scope: The guidelines include information on the apparatus and cryogens required for cryotherapy, pre-operative preparation, various techniques to be adopted in order to achieve good cosmetic results with minimal complications, post-therapy complications that can be encountered and their management, indications for cryotherapy, number of sessions required, interval between sessions and number of freeze thaw cycles for each type of lesion. An approach to minimize side effects and maximize efficacy is suggested. The complications and contraindications of this procedure are also addressed.

Physician qualification : A qualified dermatologist can undertake cryotherapy after receiving adequate training in the field during post-graduation or through recognized fellowships and workshops dedicated to cryotherapy. A 1-day demonstration workshop is adequate to learn this procedure.

Facility: Cryotherapy can be undertaken in a physician's office procedure room or minor theater with a high degree of aseptic precautions. A fully equipped minor operation theater with good lighting, appropriate minimal sterilization and storage facilities is desirable.


  Cryogen Top


The commonly used cryogens include: [15],[16],[17]

Cryogens - Boiling point

Liquid nitrogen (most commonly used) : -196°C

Nitrous oxide : - 89°C

Solidified CO 2 (dry ice, CO 2 snow) : -78°C

Chlorodifluoromethane : -41°C

Dimethyl ether and propane : -24°C, -42°C

Cryosurgery equipment

  1. Cryogun/cryogen spray canister: it is a portable, light weight, hand-held device with a controllable trigger to begin and end cooling. [15],[16],[17]
  2. Cryospray nozzle, cryprobes, spray tips, neoprene or polystyrene cones.
  3. Cryoprobes: they are available in various shapes and sizes and get attached to the cryogen. They are cooled by the spray of the cryogen.
  4. Cryogen storage device: they are metal cylinders/containers that store gaseous cryogens as compressed gas and have an inbuilt internal pressure equalization mechanism e.g., Dewar's gas container. The cryogen is transferred to the cryogun before the procedure by a siphon or by tilting the container to pour the cryogen into the gun via a funnel. Insulated gloves must be worn while transferring the cryogen. e.g., Brymill cryogenic system.



  Methodology of Cryosurgery Top


Counseling and consent: A written informed consent is obtained from the patient after explaining the procedure, the achievable results, recurrence rate and various complications of the procedure. The consent form should mention the possibility of temporary post-inflammatory blister formation and pigmentation alterations.

History taking and examination: A detailed history of general medical condition, previous treatment received for the condition with results and whether it is a primary or recurrent lesion, is taken. History of sensitivity to cold, cold urticaria, Raynaud's phenomenon or vascular insufficiency may be recorded. Physical examination to assess the skin type of the patient, lesional characteristics such as size, margin, location, depth, biological behavior and approximation to superficial nerves and previous treatment sites should be undertaken.

Pre-operative preparation: The area to be treated is adequately exposed and cleaned thoroughly with spirit or povidone iodine. Usually, intralesional or topical anesthesia is not required. It may be used for malignant lesions because a longer freeze time required to ablate deeper malignant tissue may produce severe pain. An anxious patient is counseled and an analgesic or antianxiety drug may be administered. The surrounding normal skin may be insulated to prevent spray of surrounding areas. Sites such as the eyes, nares and ears must be protected with goggles, gauze or padding.

Treatment: Different methods of applying the cryogen to the skin lesion include:

Timed spot freeze technique: The cryogen is directly sprayed onto the lesion through an appropriate sized nozzle, which is chosen according to the size of the lesion. The nozzle is held 1 cm from the skin surface and the cryogen is sprayed in the center of the lesion until an ice ball forms that completely encompasses the lesion (confirmed by palpating between the fingers) and the desired margin is reached. For adequate treatment, the lateral spread of freeze should extend at least 2 mm beyond the margin in a benign lesion and 5 mm or more for a malignant lesion. The spraying is continued for an adequate duration (holding time) after which the lesion is allowed to thaw to complete one freeze thaw cycle. Complete thawing is suggested by the disappearance of the frozen-white surface. For larger lesions (> 2 cm in diameter), different parts of the lesion are treated separately with overlapping margins.

Spot freeze can be carried out in two ways:

  1. Open spray technique - it is used for large lesions or when light superficial freeze is desired. There are two methods for open spray:

    1. Paint brush method - the lesion is treated by spraying from one side of the lesion and moving up and down across the lesion.
    2. Spiral method - the cryogen is sprayed initially in the center of the lesion and is then moved outward in concentric circles.


  2. Confined-spray technique - it is preferred for round, small, discrete lesions or those close to vital structures. In this, the range of spray is limited to a discrete area by the use of neoprene or polystyrene cones.


Use of cryoprobe: An appropriate-sized cryoprobe attached to the cryogun is directly applied to the lesion before spraying the cryogen. A thin layer of vaseline or petrolatum is applied to the probe tip to allow smooth contact with the lesion. While the cooling is occurring, the lesion gets attached to the probe, which should be raised above the surrounding normal skin by few millimeters to prevent damage to the surrounding skin. Once the lesion is frozen, it is allowed to thaw. The probe should be allowed to release spontaneously from the lesion during the thawing process and must not be pulled earlier. In this technique, a longer freezing time is required as compared with the open spray technique.

This technique is preferred in vascular lesions because direct application of the cryoprobe blanches the lesion and reduces the lesional temperature thus increasing the depth of the freeze.

Dipstick method: A cotton bud is dipped into the cryogen (liquid nitrogen slush or dry ice) placed in a disposable container and then applied firmly on the lesion until a halo of ice forms around the bud. The size of the bud should be smaller than the lesion. The depth of freeze can be increased by applying pressure on the lesion. The method has the advantage of not needing a spray or probe equipment and is therefore cheap. However, repeated applications may be necessary to achieve a proper freeze thaw.

Histofreezer: It has been primarily advocated for the treatment of warts. It is a gentler treatment than liquid nitrogen because a higher temperature is achieved, it is less expensive and is easy to store. It is a small unit containing a liquid-gas mixture of dimethyl ether and propane in an aerosol spray can. The mixture is sprayed through a narrow tube to a cotton applicator, which is applied to the wart. The mixture evaporates and freezes the wart. A temperature of -50°C is reached at the cotton tip, which freezes the wart. In a randomized trial comparing liquid nitrogen cryotherapy and histofreezer for the treatment of hand warts, patients cured of warts were 67% and 35% ( P = 0.01) and the number of warts that resolved were 66% and 49% ( P = 0.08) with the two modalities, respectively. [1] The treatments were about equally effective in dorsal non-protuberant and small (< 5 mm) warts, but the overall results of liquid nitrogen were better.

It is not available in India.

Post-treatment care

The patient is explained about the immediate skin reactions that occur post-cryotherapy. There is peripheral erythema occurring immediately to 30 min after therapy, with edema setting in within a few minutes to few hours. There may be blister formation 1-3 days later followed by crusting that lasts for up to 2 weeks. The crust falls off leaving behind a mild pinkish discoloration or erythematous atrophic scar. The patient is asked to apply a mild to moderately potent topical steroid and antibiotic combination. If the blister is large, it may be punctured with a sterile needle or aspirated with its roof left in position as a natural protective film. A non-steroidal anti-inflammatory drug (NSAID) is concomitantly administered. The treated area is best left open, washed gently with soap and water and patted dry.

Indications for cryotherapy

This procedure has been used to treat a wide variety of skin conditions shown in the appendix, e.g. [1],[2],[3],[4],[5],[6],[7],[8],[9],[10],[11],[12],[13],[14],[15],[16],[17],[18],[19],[20],[21],[22],[23],[24],[25],[26],[27],[28],[29],[30],[31],[32],[33],[34],[35],[36],[37],[38],[39],[40],[41],[42],[43],[44],[45],[46],[47],[48],[49]

  1. Vascular lesions
  2. Benign tumors
  3. Acne
  4. Pigmented lesions
  5. Viral infections
  6. Inflammatory dermatoses
  7. Infectious dermatoses
  8. Pre-malignant and malignant tumors


Note: Most of the evidence on the effectiveness of cryosurgery for the above indications comes from uncontrolled trials.

With the advent of several sophisticated ablative procedures like radiofrequency ablation or lasers, the following conditions are recommended as specific indications for cryosurgery:

  • Genital warts in HIV-positive patients or during pregnancy. [2]
  • Hemangiomas/vascular malformations - macular, flat-topped, superficial lesions, exophytic lesions or those with a subcutaneous component (deep or mixed hemangiomas and malformations). [3] (Level C evidence).
  • Well-defined, superficial non-melanoma skin cancers (basal and squamous cell carcinoma), especially located on the trunk. (Level A evidence).[4]
  • As combination therapy for lesions located on covered sites. E.g., plantar warts in combination with keratolytics, keloids in combination with I/L steroids. [5],[6]


In other dermatoses, it may be used as alternate therapy, especially under the following circumstances:

  • In old patients with pacemakers in whom electrocautery is contraindicated
  • In patients on anticoagulants
  • In subjects allergic to anesthetic agents
  • Patients with transmissible conditions such as HIV and hepatitis
  • For genital lesions during pregnancy
  • If other ablative modalities are not available


The list of dermatoses where cryotherapy has been used along with the levels of evidence are listed in the Appendix.

Complications: These are associated with inappropriate patient selection, duration of freezing and number of freeze thaw cycles undertaken. [7],[8]

Acute complications

  • Local pain - more in the periungual area, temple, plantar areas, eyelids, lips, mucous membranes. Tingling and numbness, especially on the fingers.
  • Edema, especially on the eyelids, lips, labia and prepuce, more in infants and the elderly.
  • Cryoblister formation.
  • Syncope (vasovagal reaction) in anxious patients.
  • Headache (migraine type) after the treatment of the head and neck area.


Subacute complications

  • Hemorrhagic necrosis.
  • Wound infection due to the use of infected cryoprobes or redipping cotton swabs into the cryogen.
  • Delayed wound healing after treatment over the extremities.
  • Temporary scar hypertrophy.
  • Subcutaneous emphysema due to insufflation of the underlying tissue on spraying over broken skin.


Protracted complications

Common


  • Hypopigmentation, especially in dark-skinned individuals, which can be minimized by freezing for <30s.Atrophic scar, which occurs when freezing time is >30 s.
  • Local hypoaesthesia due to nerve damage, especially in areas where the nerves lie superficially, such as the sides of fingers, angle of jaw, post-auricular area, sides of tongue and ulnar fossa of elbow.
  • Milia formation.
  • Cicatricial alopecia, which can be minimized by freezing for <30 s.


Uncommon

  • Cartilage damage.
  • Traumatic neuroma.
  • Pyogenic granuloma.
  • Fibroxanthoma.


Contraindications to cryotherapy

Absolute


  • Blood dyscrasias of unknown origin.
  • Cold intolerance.
  • Raynaud's disease.
  • Cold urticaria.
  • Cryoglobulinemia.
  • Lesions in which tissue pathology is required.
  • Lesions in areas of compromised circulation.
  • Sclerosing basal cell carcinoma (BCC) or recurrent BCC or squamous cell carcinoma (SCC ) located in high-risk areas like the temple or nasolabial folds.


Relative

  • Keloidal tendency.
  • Collagen vascular diseases.
  • Dark-skinned individuals due to the high risk of developing cosmetically inacceptable protracted hypopigmentation.
  • Lesions over the nasolabial fold, eyelid margins, ala nasi and hair-bearing areas (high risk of developing alopecia, especially cicatricial alopecia).
  • Patients with sensory loss at lesional sites.
  • Pyoderma gangrenosum.



  Conclusion Top


Cryotherapy is a simple, safe and inexpensive office procedure for the treatment of various benign, pre-malignant and well-circumscribed malignant tumors. It provides satisfactory cosmetic results with minimal complications if patient selection is proper and if it is undertaken by a trained and experienced dermatologist.

 
  References Top

1.Erkens AM, Kuijpers RJ, Knottnerus JA. An end to office hours for warts? A randomized study of the effectiveness of liquid nitrogen and of the Histofreezer. Ned Tijdschr Geneeskd 1991;135:171-4.  Back to cited text no. 1    
2.Mayeaux EJ Jr, Harper MB, Barksdale W, Pope JB. Noncervical human papilloma virus genital infections. Am Fam Physician 1995;52:1137-46.  Back to cited text no. 2  [PUBMED]  
3.Michel S, Wlotzke U, Hohenleutner U, Landthaler M. Laser and cryotherapy of hemangioma in infants in a direct comparison. Hautarzt 1998;49:192-6.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Mallon E, Dawber R. Cryosurgery in the treatment of basal cell carcinoma. Assessment of one and two freeze-thaw cycle schedules. Dermatol Surg 1996;22:854-8.  Back to cited text no. 4    
5.Zouboulis CC, Blume U, Buttner P, Orfanos CE. Outcome of cryosurgical treatment in patients with keloids and hypertrophic scars. Arch. Dermatol 1993;129:1146-51.  Back to cited text no. 5    
6.Noah S, Scheinfeld JD. Treatment of verruca vulgaris. Skinmed 2006;5:37-8.  Back to cited text no. 6    
7.Elton RF. Complications of cutaneous cryosurgery. J Am Acad Dermatol 1983;8:513-9.  Back to cited text no. 7  [PUBMED]  
8.Dawber RP. Cryosurgery: Complications and contraindications. Clin Dermatol 1991;8:96-100.  Back to cited text no. 8    
9.Thai KE, Sinclair RD. Cryosurgery of benign skin lesions. Australas J Dermatol 1999;40:175-86.  Back to cited text no. 9  [PUBMED]  [FULLTEXT]
10.Reischle S, SchullerPetrovic S. Treatment of capillary hemangiomas of early childhood with a new method of cryosurgery. J Am Acad Dermatol 2000;42:809-13.  Back to cited text no. 10    
11.Sinclair RD, Tzermias C, Dawber RP. Cosmetic cryosurgery. In: Baran R, Maibach HI eds. Textbook of Cosmetic Dermatology. London: Martin Dunitz; 1998. p. 691-700.  Back to cited text no. 11    
12.Suhonen R, Kuflik EG. Venous lakes treated by liquid nitrogen cryosurgery. Br J Dermatol 1997;137:1018-9.  Back to cited text no. 12  [PUBMED]  
13.Mirshams M, Daneshpazhooh M, Mirshekari A, Taheri A, Mansoori P, Hekmat S. Cryotherapy in the treatment of pyogenic granuloma. J Eur Acad Dermatol Venereol 2006;20:788-90.  Back to cited text no. 13  [PUBMED]  [FULLTEXT]
14.Serfling U, Hood AF. Local therapies for Kaposi's sarcoma in patients with acquired immunodeficiency syndrome. Arch Dermatol 1991;127:1479-81.  Back to cited text no. 14  [PUBMED]  [FULLTEXT]
15.Drake LA, Ceilley RI, Cornelison RL. Guidelines for care for cryosurgery. J Am Acad Dermatol 1994;31:648-53.  Back to cited text no. 15    
16.Kuflik EG. Cryosurgery updated. J Am Acad Dermatol 1994;31:925-44.  Back to cited text no. 16  [PUBMED]  
17.Graham GF. Cryosurgery. Clin Plast Surg 1993;20:131-47.  Back to cited text no. 17  [PUBMED]  
18.Apaydin R, Bilen N, Bayramgürler D, Ba?da? F, Harova G, Dφkmeci S. Steatocystoma multiplex suppurativum: Oral isotretinoin treatment combined with cryotherapy. Australas J Dermatol 2000;41:98-100.  Back to cited text no. 18    
19.Luba MC, Bangs SA, Mohler AM, Stulberg DL. Common benign skin tumors. Am Fam Physician 2003;67:729-38.  Back to cited text no. 19    
20.Lanigan SW, Robinson TW. Cryosurgery for dermatofibromas. Clin Exp Dermatol 1987;12:121-3.  Back to cited text no. 20    
21.Andrews MD. Cryosurgery for common skin conditions. Am Fam Physician 2004;69:2365-72.  Back to cited text no. 21    
22.Kosann MK. Inflammatory linear verrucous epidermal nevus. Dermatol Online J 2003;9:15.   Back to cited text no. 22    
23.Shroff HJ. Current approach to the management of nevi. Indian J Pediatr 1983;50:545-6.  Back to cited text no. 23    
24.Hawk JL. Cryotherapy may be effective for eyelid xanthelasma. Clin Exp Dermatol 2000;25:351.  Back to cited text no. 24    
25.Bhushan M, Craven NM, Beck MH, Chalmers RJ. Linear porokeratosis of Mibelli:successful treatment with cryotherapy. Br J Dermatol 1999;141:389-90.  Back to cited text no. 25    
26.Rosenblum GA. Liquid nitrogen cryotherapy in a case of elastosis perforans serpiginosa. J Am Acad Dermatol 1983;8:718-21.   Back to cited text no. 26    
27.Blume U, Zouboulis ChC, Jacobi H, Scholz A, Bisson S, Orfanos CE. Successful outcome of cryosurgery in patients with granuloma anulare. Br J Dermatol 1994;130:494-7.  Back to cited text no. 27    
28.Graham GF. Cryosurgery for acne. In: Zacarian SA, editor. Cryosurgery for Skin Cancer and Cutaneous Disorders. St Louis: Mosby Press; 1985. p. 59-76.  Back to cited text no. 28    
29.Layton AM. A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne keloids. Br J Dermatol 1994;130:498-501.  Back to cited text no. 29    
30.Connolly M, Bazmi K, O'Connell M, Lyons JF, Bourke JF. Cryotherapy of viral warts: A sustained 10-s freeze is more effective than the traditional method. Br J Dermatol 2001;145:554-7.  Back to cited text no. 30    
31.Stone KM, Becker TM, Hadgu A, Kraus SJ. Treatment of external genital warts: A randomized clinical trial comparing podophyllin, cryotherapy and electrodessication. Genitourin Med 1990;66:16-9.  Back to cited text no. 31    
32.Sherrard J, Riddell L. Comparison of the effectiveness of commonly used clinic-based treatments for external genital warts. Int J STD AIDS 2007;18:365-8.  Back to cited text no. 32    
33.Kumarasinghe SP. 3-5 second cryotherapy is effective in idiopathic guttate hypomelanosis. J Dermatol 2004;31:437-9.  Back to cited text no. 33    
34.Ploysangam T, Dee-Ananlap S, Suvanprakorn P. Treatment of idiopathic guttate hypomelanosis with liquid nitrogen: light and electron microscopic studies. J Am Acad Dermatol 1990;23:681-4.  Back to cited text no. 34    
35.Colver GB, Dawber RP. Tattoo removal using a liquid nitrogen cryospray. Clin Exp Dermatol 1984;9:364-6.  Back to cited text no. 35    
36.Dawber R, Graham C, Jackson A. Benign lesions. In: Cutaneous Cryosurgery: Principles and Clinical Practice. London: Martin Dunitz Ltd; 1992. p. 29-76.  Back to cited text no. 36    
37.Hexsel DM, Mazzuco R, Bohn J, Borges J, Gobbato DO. Clinical comparative study between cryotherapy and local dermabrasion for the treatment of solar lentigo on the back of the hands. Dermatol Surg 2000;26:457-62.  Back to cited text no. 37    
38.Stern RS, Dover JS, Levin JA, Arndt KA. Laser therapy versus cryotherapy of lentigines: a comparative trial. J Am Acad Dermatol 1994;30:985-7.  Back to cited text no. 38    
39.Ishida CE and Ramos-e-Silva M. Cryosurgery in oral lesions. Int J Dermatol 1998;37:283-5.  Back to cited text no. 39    
40.Al-Majali O, Routh HB, Abuloham O, Bhowmik KR, Muhsen M, Hebeheba H. A 2-year study of liquid nitrogen therapy in cutaneous leishmaniasis. Int J Dermatol 1997;36:460-2.  Back to cited text no. 40    
41.Bonifaz A, Martinez-Soto E, Carrasco-Gerard E, Peniche J. Treatment of chromoblastomycosis with itraconazole, cryosurgery, and a combination of both. Int J Dermatol 1997;36:542-7.  Back to cited text no. 41    
42.Lubritz RR, Smolewski SA. Cryosurgery cure rate of actinic keratoses. J Am Acad Dermatol 1982;7:631-2.  Back to cited text no. 42    
43.Sinclair RD, Dawber RP. Cryosurgery of malignant and premalignant diseases of the skin:A simple approach. Australas J Dermatol 1995;36:133-42.  Back to cited text no. 43    
44.Zacarian SA. Cryosurgery of cutaneous carcinomas: An 18-year study of 3,022 patients with 4,288 carcinomas. J Am Acad Dermatol 1983;9:947-56.   Back to cited text no. 44    
45.Kuflik EG, Gage AA. The five-year cure rate achieved by cryosurgery for skin cancer. J Am Acad Dermatol 1991;24:1002-4.   Back to cited text no. 45    
46.Graham GF, Clark LC. Statistical analysis in cryosurgery of skin cancer. Clin Dermatol 1990;8:101-7.   Back to cited text no. 46    
47.Holt PJ. Cryotherapy for skin cancer: results over a 5-year period using liquid nitrogen spray cryosurgery. Br J Dermatol 1988;119:231-40.  Back to cited text no. 47    
48.Kuflik EG. Cryosurgery for skin cancer: 30-year experience and cure rates. Dermatol Surg 2004;30:297-300.  Back to cited text no. 48    
49.Weyer U, Petersen J, Ehrke C, Carstensen A, Nüssgen A, Russ C, et al . Immunmodulation durch Kryochirurgie beim malignen Melanom. Onkologie 1989;12:291-6.  Back to cited text no. 49    



This article has been cited by
1 Cryotherapy - A review
Sunitha, J.
Journal of Clinical and Diagnostic Research. 2010; 4(2): 2325-2329
[Pubmed]



 

Top
Print this article  Email this article
Previous article Next article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow